Skip to main content
Clinical Trials/NCT04304378
NCT04304378
Completed
N/A

Enhancing Capacity for Mental Health Research and Care in Cambodia: Trauma Informed Treatment Algorithms for Novel Outcomes

University of Missouri, St. Louis2 sites in 1 country198 target enrollmentOctober 5, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Post-Traumatic Stress Disorder
Sponsor
University of Missouri, St. Louis
Enrollment
198
Locations
2
Primary Endpoint
Percent of study participants who no longer screen positive for PTSD at four months using the PCL-5 questionnaire.
Status
Completed
Last Updated
last year

Overview

Brief Summary

This randomized controlled trial (RCT) will examine the feasibility, acceptability, and preliminary efficacy of a beginning treatment for Post-Traumatic Stress Disorder (PTSD) with Behavioral Activation (BA). Cambodian men and women who screen positive for PTSD will be randomized to receive six individually delivered sessions of either: 1) Stabilization Techniques alone (ST); or 2) ST+BA. After two months, all participants who continue to report clinically meaningful elevations in PTSD will receive Eye Movement Desensitization Reprocessing (EMDR). All participants will complete a follow-up assessment at four months post-randomization.

Detailed Description

Nearly half of the Cambodian population reports elevated levels of psychological distress and PTSD. The high levels of psychological distress are linked directly to the report of remote and more recent trauma exposures, the most notable of which is the agrarian political regime of the Khmer Rouge during the 1970s, which occurred in the aftermath of the Vietnam War. During this period, approximately 1.5 million Cambodian residents died of starvation and sickness, 500,000 individuals were executed, and another two million were displaced over the course of several years. Political stability took shape in the early 1990s after the enactment of the United Nations Transitional Authority in Cambodia. However, the prior violence undermined an already fragile healthcare system, including mental health institutions and physicians providing direct patient care. The combination of high trauma exposure, sustained conflict, and limited psychiatric capacity has created heightened vulnerability for Cambodians, and the need to assist those struggling with PTSD. There is a pressing need to reverse this trajectory using novel approaches to address mental health needs that are effective and scalable, providing a strong basis to conduct the proposed work in Cambodia. In partnership with the Cambodian Department of Mental Health and Substance Abuse, Ministry of Health, this NIH-sponsored study will examine the feasibility, acceptability, and preliminary efficacy integrating BA into trauma treatment that is being delivered by the Mekong Project in Cambodia.

Registry
clinicaltrials.gov
Start Date
October 5, 2020
End Date
March 6, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Missouri, St. Louis
Responsible Party
Principal Investigator
Principal Investigator

Robert Paul

Curators' Distinguished Professor

University of Missouri, St. Louis

Eligibility Criteria

Inclusion Criteria

  • Trauma exposure and screens positive for PTSD as measured by the DSM-5 PTSD Checklist (PCL-5), a 20-item scale to measure severity of PTSD symptoms
  • Able to communicate in Khmer
  • Able to provide informed consent as defined by ability to accurately paraphrase the purpose

Exclusion Criteria

  • Active psychosis or developmental disorder that precludes an individual's ability to provide informed consent
  • Severe alcohol or substance use disorder a determined by the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST)
  • Use of psychiatric medications will be allowed but our preliminary work revealed fewer than 5% of all individuals receive medications for PTSD

Outcomes

Primary Outcomes

Percent of study participants who no longer screen positive for PTSD at four months using the PCL-5 questionnaire.

Time Frame: 4 months

Secondary Outcomes

  • Culturally-Relevant PTSD Symptoms(4 months)
  • Alcohol and Substance Use(4 months)
  • Psychological Distress(4 months)

Study Sites (2)

Loading locations...

Similar Trials